Topic
Drug Labeling
96 published works
Drug & Device Law
New Jersey OTC Preemption Decision
We don’t spend much time on this blog on over-the-counter (“OTC”) drugs, but when OTC crosses paths with preemption in our own backyard, we can’t help but be interested. …
Health Industry Washington Watch
FDA Small Entity Compliance Guidance: Toll Free Number Labeling for Drugs
This post was written by Erin Janssen. The FDA has published a Small Entity Compliance Guide entitled "Toll-Free Number Labeling and Related Requirements for Over-the-Counter and Prescription Drugs Marketed With…
Health Industry Washington Watch
FDA Issues Final Guidance on Risk Labeling for Prescription Drugs and Biological Products
This post was written by Erin Janssen and Areta Kupchyk. On October 12, 2011 the FDA announced the availability of guidance for the industry entitled “Warnings and Precautions, Contraindications, and…
Health Law Prof Blog
Stacey B. Lee: “Generic Manufacturers’ Labeling Catch-22”
Stacey B. Lee, Assistant Professor at Johns Hopkins University Carey Business School, posted, "Generic Manufacturers' Labeling Catch-22" on SSRN: In Wyeth v. Levine, the Supreme Court eliminated brand-name manufacturers’ ability…
Ad Law Access
Supreme Court Rules on Generic Drug Labeling Preemption
By Kelley Drye
On June 23, 2011, the Supreme Court rendered its decision in Pliva, Inc. v. Mensing holding that FDA regulations governing generic drug products directly conflict with and preempt state laws…
Drug & Device Law
While We Wait On Mensing, Another Circuit Shoots Down Generic Preemption
By will
We’re all curious to see what the Supreme Court does with the generic prescription drug manufacturers’ preemption defense in Actavis Elizabeth, LLC v. Mensing, which is scheduled for argument on…
The Appellate Strategist
Justice Kagan and the Future of Generic Drug Preemption
By Kelly Savage
US Supreme Court Will Decide Fate of Preemption Defense for Generic Companies this Term Since the decision of the Supreme Court in Wyeth v. Levine, 129 S.Ct. 1187 (2009), the…
Drug & Device Law
Thoughts on the Tegretol Complaint
A new lawsuit was filed in our favorite Judicial Hellhole, Madison County, Illinois, alleging that a pharmaceutical company failed to warn that African-Americans face an elevated risk of certain dermatological…
Drug & Device Law
Bam, bam, bam
Bam, bam, bam. That’s the sound – not to be confused with Wham!, Bam!, or even Bamm-Bamm – of another nail being driven into the coffin of Conte v. Wyeth,…
Health Industry Washington Watch
FDA Guidance on Content and Format of the Dosage and Administration Section of Labeling
FDA issued a final guidance document entitled “Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products--Content and Format.'' The guidance identifies information that should be included…